Atria Investments LLC bought a new stake in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) in the first quarter, HoldingsChannel reports. The institutional investor bought 2,552 shares of the company’s stock, valued at approximately $207,000.

Other hedge funds have also made changes to their positions in the company. BlackRock Inc. boosted its position in shares of U.S. Physical Therapy by 2.5% in the fourth quarter. BlackRock Inc. now owns 1,621,087 shares of the company’s stock worth $117,043,000 after purchasing an additional 40,093 shares during the period. UBS Asset Management Americas Inc. bought a new position in shares of U.S. Physical Therapy in the fourth quarter worth approximately $206,000. Bank of Montreal Can boosted its position in shares of U.S. Physical Therapy by 35.6% in the fourth quarter. Bank of Montreal Can now owns 4,535 shares of the company’s stock worth $327,000 after purchasing an additional 1,191 shares during the period. Copeland Capital Management LLC bought a new position in shares of U.S. Physical Therapy in the fourth quarter worth approximately $12,459,000. Finally, Algert Global LLC boosted its position in shares of U.S. Physical Therapy by 89.4% in the fourth quarter. Algert Global LLC now owns 33,565 shares of the company’s stock worth $2,423,000 after purchasing an additional 15,845 shares during the period. 95.26% of the stock is owned by institutional investors and hedge funds.

In related news, COO Glenn Mcdowell sold 2,900 shares of the company’s stock in a transaction on Thursday, March 15th. The shares were sold at an average price of $82.55, for a total transaction of $239,395.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Christopher J. Reading sold 13,639 shares of the stock in a transaction on Wednesday, May 9th. The shares were sold at an average price of $92.01, for a total transaction of $1,254,924.39. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 36,954 shares of company stock valued at $3,268,861. 2.50% of the stock is owned by company insiders.

Shares of U.S. Physical Therapy opened at $92.00 on Thursday, MarketBeat reports. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.67 and a quick ratio of 1.67. U.S. Physical Therapy, Inc. has a fifty-two week low of $90.70 and a fifty-two week high of $91.05. The firm has a market cap of $1.15 billion, a P/E ratio of 42.69, a P/E/G ratio of 3.28 and a beta of 1.09.

U.S. Physical Therapy (NYSE:USPH) last issued its earnings results on Thursday, May 3rd. The company reported $0.56 earnings per share for the quarter, hitting the Zacks’ consensus estimate of $0.56. U.S. Physical Therapy had a net margin of 4.90% and a return on equity of 13.20%. The firm had revenue of $108.34 million during the quarter, compared to analyst estimates of $107.18 million. research analysts anticipate that U.S. Physical Therapy, Inc. will post 2.45 earnings per share for the current year.

The business also recently announced a quarterly dividend, which will be paid on Friday, June 8th. Investors of record on Friday, May 11th will be given a dividend of $0.23 per share. The ex-dividend date of this dividend is Thursday, May 10th. This represents a $0.92 dividend on an annualized basis and a dividend yield of 1.00%. U.S. Physical Therapy’s dividend payout ratio is 44.23%.

A number of equities analysts have weighed in on USPH shares. Cantor Fitzgerald reiterated a “buy” rating and issued a $90.00 price target on shares of U.S. Physical Therapy in a research report on Thursday, May 3rd. Zacks Investment Research upgraded shares of U.S. Physical Therapy from a “hold” rating to a “buy” rating and set a $89.00 price target for the company in a research report on Wednesday, March 7th. Sidoti lowered shares of U.S. Physical Therapy from a “buy” rating to a “neutral” rating in a research report on Wednesday, April 25th. ValuEngine upgraded shares of U.S. Physical Therapy from a “hold” rating to a “buy” rating in a research report on Monday, April 2nd. Finally, Barrington Research reiterated a “hold” rating on shares of U.S. Physical Therapy in a research report on Friday, March 9th. Six equities research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company’s stock. U.S. Physical Therapy has an average rating of “Hold” and a consensus price target of $79.40.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

Want to see what other hedge funds are holding USPH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for U.S. Physical Therapy, Inc. (NYSE:USPH).

Institutional Ownership by Quarter for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.